24
Participants
Start Date
June 15, 2018
Primary Completion Date
July 22, 2020
Study Completion Date
July 22, 2020
Risedronate Sodium 150 MG
Subjects randomized to the Risedronate group will take a 150 mg capsule of oral Risedronate once every 4 weeks for 24 weeks (6 doses), beginning 1 week prior to surgery and dispensed in blinded capsules from the WFSM research pharmacy.
Placebo
Participants randomized to the placebo group will receive 150 mg placebo capsule once every 4 weeks for 24 weeks (6 doses), beginning 1 week prior to surgery and dispensed in blinded capsules from the WFSM research pharmacy.
Wake Forest University, Winston-Salem
Wake Forest University
OTHER
Wake Forest University Health Sciences
OTHER